Even is better than odd: One fat may conceal another

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 7, 2015, Pages H1112-H1114

  Beauloye, Christophe ^a,b   Horman, Sandrine ^a   Bertrand, Luc ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID; PROPIONYL COENZYME A; SUCCINYL COENZYME A; HEPTANOIC ACID DERIVATIVE; OCTANOIC ACID DERIVATIVE;

CITRIC ACID CYCLE; EDITORIAL; ENERGY YIELD; EXTRACORPOREAL OXYGENATION; FATTY ACID OXIDATION; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE METABOLISM; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DRUG EFFECTS; HEART; HEART MUSCLE; MALE; METABOLISM;

ANIMALS; CAPRYLATES; CITRIC ACID CYCLE; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART; HEPTANOATES; MALE; MYOCARDIUM;

EID: 84943149541     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00620.2015     Document Type: Editorial

References (22)

1. Beauloye C, Bertrand L, Horman S, Hue L. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res 90: 224-233, 2011.
2. Brunengraber H, Roe CR. Anaplerotic molecules: current and future. J Inherit Metab Dis 29: 327-331, 2006.
3. Czibik G, Steeples V, Yavari A, Ashrafian H. Citric acid cycle intermediates in cardioprotection. Circ Cardiovasc Genet 7: 711-719, 2014.
4. Dassanayaka S, Jones SP. O-GlcNAc and the cardiovascular system. Pharmacol Ther 142: 62-71, 2014.
5. Des Rosiers C, Labarthe F, Lloyd SG, Chatham JC. Cardiac anaplerosis in health and disease: food for thought. Cardiovasc Res 90: 210-219, 2011.
6. Fillmore N, Lopaschuk GD. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochim Biophys Acta 1833: 857-865, 2013.
7. Gupta P, McDonald R, Chipman CW, Stroud M, Gossett JM, Imamura M, Bhutta AT. 20-year experience of prolonged extracorporeal membrane oxygenation in critically ill children with cardiac or pulmonary failure. Ann Thorac Surg 93: 1584-1590, 2012.
8. Harmancey R, Vasquez HG, Guthrie PH, Taegtmeyer H. Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart. FASEB J 27: 3966-3978, 2013.
9. Horman S, Beauloye C, Vanoverschelde JL, Bertrand L. AMP-activated protein kinase in the control of cardiac metabolism and remodeling. Curr Heart Fail Rep 9: 164-173, 2012.
10. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 297: E578-E591, 2009.
11. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation-a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta 1813: 1333-1350, 2011.
12. Kajimoto M, Ledee DR, Olson AK, Isern NG, Des Rosiers C, Portman MA. Differential effects of octanoate and heptanoate on myocardial metabolism during extracorporeal membrane oxygenation in an infant swine model. Am J Physiol Heart Circ Physiol 309: H0-H0, 2015. doi:10.1152/ajpheart.00298.2015.
13. Kajimoto M, O'Kelly Priddy CM, Ledee DR, Xu C, Isern N, Olson AK, Des Rosiers C, Portman MA. Myocardial reloading after extracorporeal membrane oxygenation alters substrate metabolism while promoting protein synthesis. J Am Heart Assoc 2: e000106, 2013.
14. Kajimoto M, O'Kelly Priddy CM, Ledee DR, Xu C, Isern N, Olson AK, Portman MA. Extracorporeal membrane oxygenation promotes long chain fatty acid oxidation in the immature swine heart in vivo. J Mol Cell Cardiol 62: 144-152, 2013.
15. Kolwicz SC Jr, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 113: 603-616, 2013.
16. Labarthe F, Gelinas R, Des Rosiers C. Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc Drugs Ther 22: 97-106, 2008.
17. Labarthe F, Khairallah M, Bouchard B, Stanley WC, Des Rosiers C. Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. Am J Physiol Heart Circ Physiol 288: H1425-H1436, 2005.
18. Ledee DR, Kajimoto M, O'Kelly Priddy CM, Olson AK, Isern N, Robillard-Frayne I, Des Rosiers C, Portman MA. Pyruvate modifies metabolic flux and nutrient sensing during extracorporeal membrane oxygenation in an immature swine model. Am J Physiol Heart Circ Physiol 309: H137-H146, 2015.
19. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010.
20. Merrill ED, Schoeneberg L, Sandesara P, Molitor-Kirsch E, O'Brien J Jr, Dai H, Raghuveer G. Outcomes after prolonged extracorporeal membrane oxygenation support in children with cardiac disease-Extracorporeal Life Support Organization registry study. J Thorac Cardiovasc Surg 148: 582-588, 2014.
21. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
22. Okere IC, McElfresh TA, Brunengraber DZ, Martini W, Sterk JP, Huang H, Chandler MP, Brunengraber H, Stanley WC. Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemia-reperfusion. J Appl Physiol 100: 76-82, 2006.